Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06430320 · ClinicalTrials.gov registry record
Ascertaining Longterm Outcomes of Fibroid Treatments
A clinical trial, sponsored by Henry Ford Health System.
- Active
- Registry status
- 700
- Enrollment target
NCT06430320 is a clinical trial that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 700 participants.
The verdict
NCT06430320 is active but no longer recruiting, sponsored by Henry Ford Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 700 participants
- Enrollment target
Study Summary
The goal of the ALOFT study is to understand the health of women in the 12 years following a uterine fibroid (UF) treatment. ALOFT is a multi-center, prospective, observational cohort study of approximately 700 women who have undergone uterine-sparing treatment procedures for UF and previously participated in the longitudinal studies COMPARE-UF (NCT02260752) or ULTRA (NCT02100904). The primary uterine sparing treatment procedures undergone by study participants are myomectomy, endometrial ablation (EA), uterine artery embolization (UAE) and laparoscopic radiofrequency ablation (RFA). A smaller number of women may be studied who underwent focused ultrasound, intrauterine device (IUD), and medical management. Two follow-up study contacts with COMPARE-UF and ULTRA participants will occur to assess changes in UF symptoms and treatment failure which is defined as the need for another UF treatment procedure. Questionnaires will be used to collect data on patient-reported characteristics and outcomes and quality of life. The study's analyses will focus on comparisons of primary and secondary outcomes among women.
Interventions
- OTHER NA- no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2024-05-20 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06430320
The ClinicalTrials.gov registry entry for NCT06430320 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NA- no intervention is the first listed.
NCT06430320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06430320 about?
NCT06430320 is a clinical study titled "Ascertaining Longterm Outcomes of Fibroid Treatments". The goal of the ALOFT study is to understand the health of women in the 12 years following a uterine fibroid (UF) treatment. ALOFT is a multi-center, prospective, observational cohort study of approximately 700 women who have undergone uterine-sparing treatment procedures for UF and previously parti...
What is the current status of trial NCT06430320?
This trial is currently active not recruiting. The enrollment target is 700 participants. The study started on 2024-05-20. Estimated completion is 2027-08.
What interventions are being tested in trial NCT06430320?
The interventions under investigation include: NA- no intervention (OTHER).
Who is sponsoring clinical trial NCT06430320?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.